Resistance to endotoxic shock in mice lacking natriuretic peptide receptor-A

作者: Catherine M Panayiotou , Reshma Baliga , Raymond Stidwill , Valerie Taylor , Mervyn Singer

DOI: 10.1111/J.1476-5381.2010.00830.X

关键词:

摘要: Background and purpose:  Excessive production of nitric oxide (NO) by inducible NO synthase (iNOS) is thought to underlie the vascular dysfunction, systemic hypotension organ failure that characterize endotoxic shock. Plasma levels atrial natriuretic peptide (ANP), brain (BNP) C-type (CNP) are raised in animal models humans with shock correlate associated cardiovascular dysfunction. Since both peptides play important roles homeostasis via activation guanylate cyclase-linked receptors, we used mice lacking receptor (NPR)-A (NPR1) establish if contribute dysfunction present shock. Experimental approach:  Wild-type (WT) NPR-A knockout (KO) were exposed lipopolysaccharide (LPS) (in vitro vivo), pro-inflammatory cytokines, iNOS expression activity evaluated. Key results:  LPS-treated WT animals exhibited a marked fall mean arterial blood pressure (MABP) whereas KO maintained MABP throughout. LPS administration caused greater suppression responses thromboxane-mimetic U46619, ANP, acetylcholine NO-donor spermine-NONOate versus mice. This differential effect on function was paralleled reduced cytokine production, (plasma [NOx] cyclic GMP). Conclusions implications:  These observations suggest facilitates contributes characteristic Pharmacological interventions target system may represent novel approach treat this life-threatening condition.

参考文章(44)
Richard S. Hotchkiss, Irene E. Karl, The pathophysiology and treatment of sepsis. The New England Journal of Medicine. ,vol. 348, pp. 138- 150 ,(2003) , 10.1056/NEJMRA021333
S. L. Milgram, O. Smithies, N. Maeda, P. M. Oliver, J. E. Fox, R. Kim, H. A. Rockman, H.-S. Kim, R. L. Reddick, K. N. Pandey, Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 14730- 14735 ,(1997) , 10.1073/PNAS.94.26.14730
Johann K. Scicluna, Arnaud Mansart, Jonathan J. Ross, Charles S. Reilly, Nicola J. Brown, Zoë L.S. Brookes, Reduced vascular response to phenylephrine during exposure to lipopolysaccharide in vitro involves nitric oxide and endothelin 1. Shock. ,vol. 29, pp. 417- 421 ,(2008) , 10.1097/SHK.0B013E318142C5DF
Monira B Hussain, Adrian J Hobbs, Raymond J MacAllister, Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta British Journal of Pharmacology. ,vol. 128, pp. 1082- 1088 ,(1999) , 10.1038/SJ.BJP.0702874
D D Rees, J E Monkhouse, D Cambridge, S Moncada, Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. British Journal of Pharmacology. ,vol. 124, pp. 540- 546 ,(1998) , 10.1038/SJ.BJP.0701815
Robert G. Kilbourn, Amal Jubran, Steven S. Gross, Owen W. Griffith, Roberto Levi, James Adams, Robert F. Lodato, Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochemical and Biophysical Research Communications. ,vol. 172, pp. 1132- 1138 ,(1990) , 10.1016/0006-291X(90)91565-A
Rochus Witthaut, Christian Busch, Peter Fraunberger, Autar Walli, Dietrich Seidel, G�nter Pilz, Ralph Stuttmann, Norbert Speichermann, Ljifane Verner, Karl Werdan, Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Medicine. ,vol. 29, pp. 1696- 1702 ,(2003) , 10.1007/S00134-003-1910-0
Koen J. Hartemink, A. B. Johan Groeneveld, Marcel C. M. de Groot, Rob J. M. Strack van Schijndel, Gerard van Kamp, Lambertus G. Thijs, α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock Critical Care Medicine. ,vol. 29, pp. 80- 87 ,(2001) , 10.1097/00003246-200101000-00019